MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Investigating factors contributing to clinical trial recruitment in Parkinson’s Disease within the Black community

J. Adrissi, C. Onwumere, D. Dominguez, M. Lyleroehr, E. Gray, K. Williams, E. Zivin, D. Larson (Los Angeles, USA)

Meeting: 2023 International Congress

Abstract Number: 18

Keywords: Parkinson’s

Category: Parkinson’s Disease: Clinical Trials

Objective: This study aimed to investigate the facilitators and barriers to Parkinson’s disease (PD) research engagement within Black people with PD and Black healthy controls.

Background: A growing body of literature describes disparities in PD within the Black population, from PD awareness and diagnosis to management and outcomes. Compounding these disparities is inequitable access to PD trials. Only 1.7% of PD clinical trial enrollees to date have identified as Black or African American. This underrepresentation limits the generalizability and validity of research findings and creates a gap in our understanding of the disease in this population.

Method: Thirty participants (15 Black participants with PD and 15 Black healthy controls) completed a survey which included demographics, past research participation, personal/family history of PD, and questions on views toward clinical research. The survey was followed by a semi-structured interview covering (1) perceptions of PD, (2) thoughts and experience with clinical research, and (3) recommendations for engaging the Black community in PD research.

Results: Thirteen of the 15 participants with PD and all the healthy controls agreed that they would strongly consider participating in a study if their doctor recommended it, and 11 of 15 participants with PD and 12 of 15 healthy controls were interested in learning about studies they might participate in. Barriers identified included time, transportation, location, lack of awareness of PD and research opportunities, and lack of a trusting relationship with the medical research field. Facilitators to research engagement included transparency and education on PD and research opportunities, culturally congruent research team members, convenience/flexibility, compensation, and academic-community partnerships.

Conclusion: There is a significant interest in PD research participation in the Black community. Sustainable, long-term initiatives using community-partnered and -located education, relationship-building, and recruitment are possible solutions to address identified barriers and increase the representation of Black participants in PD clinical trials.

To cite this abstract in AMA style:

J. Adrissi, C. Onwumere, D. Dominguez, M. Lyleroehr, E. Gray, K. Williams, E. Zivin, D. Larson. Investigating factors contributing to clinical trial recruitment in Parkinson’s Disease within the Black community [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/investigating-factors-contributing-to-clinical-trial-recruitment-in-parkinsons-disease-within-the-black-community/. Accessed May 23, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/investigating-factors-contributing-to-clinical-trial-recruitment-in-parkinsons-disease-within-the-black-community/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley